Yuyu Pharma (XKRX:000220) COGS-to-Revenue : 0.67 (As of Dec. 2023)

View and export this data going back to 1975. Start your Free Trial

What is Yuyu Pharma COGS-to-Revenue?

Yuyu Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was ₩23,276 Mil. Its Revenue for the three months ended in Dec. 2023 was ₩34,608 Mil.

Yuyu Pharma's COGS to Revenue for the three months ended in Dec. 2023 was 0.67.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Yuyu Pharma's Gross Margin % for the three months ended in Dec. 2023 was 32.75%.

Yuyu Pharma COGS-to-Revenue Historical Data

The historical data trend for Yuyu Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuyu Pharma COGS-to-Revenue Chart

Yuyu Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.54

0.61

0.62

0.64

Yuyu Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.61	0.60	0.63	0.67	0.67

Yuyu Pharma COGS-to-Revenue Calculation

Yuyu Pharma's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	88312.981	/	137209.589
	=	0.64

Yuyu Pharma's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	23275.53	/	34608.469
	=	0.67

Yuyu Pharma (XKRX:000220) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Yuyu Pharma's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	23275.53 / 34608.469
	=	32.75 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Yuyu Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yuyu Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuyu Pharma (XKRX:000220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuyu Pharma Inc (XKRX:000220) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

000227.PFD:Korea 000225.PFD:Korea

Address

197, Dongho-ro, Yuyu Building, Jung-gu, Seoul, KOR

Website

http://www.yuyu.co.kr

Yuyu Pharma Inc. manufactures and markets medicines. The major product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Yuyu Pharma (XKRX:000220) Headlines

No Headlines